Continuous glucose monitoring versus finger‑stick checks in pregnancy with type 2 diabetes
Official title: Maternal Continuous Glucose Monitoring Surveillance Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Run by Thomas Jefferson University · NCT07184775 · Data updated 2026-11-12
This trial tests whether wearing a continuous glucose monitor helps pregnant people with type 2 diabetes keep up with blood sugar checks more than traditional finger‑stick testing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 70 (estimated) |
| Sponsor | Thomas Jefferson University Academic / other |
| Locations | 2 sites (Sewell, New Jersey and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | March 1, 2026 |
| Study ends | March 1, 2026 |
| Registry record updated | October 14, 2025 |
| Trial ID | NCT07184775 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant people with singleton pregnancies and pregestational type 2 diabetes who start prenatal care before 20 weeks and can wear a continuous glucose monitor.
✕Probably not a fit
People with type 1 diabetes, those allergic to insulin, or those unable or unwilling to wear a CGM are unlikely to benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial assigns pregnant people with pregestational type 2 diabetes to either standard finger‑stick glucose monitoring or to wearing a continuous glucose monitor during pregnancy. The main goal is to compare adherence to glucose monitoring between the two methods, with secondary analyses of maternal glycemic control and neonatal outcomes. Eligible participants are those with singleton pregnancies without fetal anomalies who begin prenatal care before 20 weeks; people with type 1 diabetes, insulin allergy, or inability to wear a CGM are excluded. Medication adjustments follow routine clinical care based on the glucose data collected from the assigned monitoring method.
Why it matters
Potential benefit: If successful, CGMs could make it easier to track blood sugar during pregnancy and lead to better glucose control and healthier newborn outcomes.
How similar studies have gone: Previous studies in pregnancy and other diabetes populations have shown CGMs increase monitoring adherence and improve glycemic control, but randomized evidence specifically in pregestational T2DM pregnancies is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * singleton pregnancies * fetuses without anomalies * diagnosis of Type 2 diabetes * initiation of prenatal care at \<20 weeks gestation Exclusion Criteria: * diagnosis of Type 1 diabetes * allergy to insulin * inability to wear a continuous glucose monitor
Where it's running
-
Jefferson Health New Jersey
Sewell, New Jersey, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Brandy Firman
- Email: brandy.firman@jefferson.edu
- Phone: 215-955-8401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using continuous glucose monitoring to manage type 2 diabetes during pregnancy
This study is testing whether using continuous glucose monitoring can help pregnant people with type 2 diabetes manage their blood sugar better than traditional self-monitoring methods.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Lifestyle change program to help type 2 diabetes go into remission in Pakistan
This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.